EyeGate Pharmaceuticals

EyeGate Pharmaceuticals

EyeGate Pharma | Advanced therapeutics and drug delivery mechanisms for ophthalmic care.

HQ location
Waltham, United States
Website
eyegatepharma.com
Launch date
Enterprise value
$92—138k
Share price
$35.65 EYEG
Recent deals
https://twitter.com/eyegatepharma
    • Edit
loading funding rounds…
Innoven Partners
Innoven Partners(exited)
Nexus Medical Partners
Nexus Medical Partners(exited)
Ventech
Ventech(exited)
Medicis Capital
Medicis Capital(exited)
Natixis Private Equity
Natixis Private Equity(exited)
Generis Capital Partners
Generis Capital Partners(exited)
Nantahala Capital Management
Nantahala Capital Management
Stonepine Capital Management
Stonepine Capital Management
ADAR1 Partners
ADAR1 Partners
Rosalind Capital Partners
Rosalind Capital Partners
Velan Capital
Velan Capital

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by EyeGate Pharmaceuticals

Edit
Panoptes Pharma
Panoptes Pharma
ACQUISITION by EyeGate Pharmaceuticals Dec 2020
Jade Therapeutics
Jade Therapeutics
ACQUISITION by EyeGate Pharmaceuticals Mar 2016